Ethionamide Interactions
Showing entire list of all interactions, including brand names and combination drugs.
Go back to interactions summary
Medications known to interact with ethionamide
A
- Ablysinol (ethanol)
- Abraxane (paclitaxel protein-bound)
- Abrilada (adalimumab)
- Accolate (zafirlukast)
- acetohexamide
- Actemra (tocilizumab)
- adalimumab
- Adcetris (brentuximab)
- Admelog (insulin lispro)
- ado-trastuzumab emtansine
- Advicor (lovastatin / niacin)
- Afrezza (insulin inhalation, rapid acting)
- Alcohol (contained in alcoholic beverages) (ethanol)
- Alcohol 5% in Dextrose 5% (ethanol)
- Alcohol And Dextrose Injections USP Hypertonic (ethanol)
- Altocor (lovastatin)
- Altoprev (lovastatin)
- Amaryl (glimepiride)
- Amersham Indium (111In) Oxine (indium oxyquinoline in-111)
- amiodarone
- Amjevita (adalimumab)
- amlodipine / atorvastatin
- Antabuse (disulfiram)
- Apidra (insulin glulisine)
- Apidra SoloStar (insulin glulisine)
- Apresazide (hydralazine / hydrochlorothiazide)
- Apresoline (hydralazine)
- Aralen (chloroquine)
- Aralen Hydrochloride (chloroquine)
- Aralen Phosphate (chloroquine)
- Arava (leflunomide)
- Arranon (nelarabine)
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- Asparlas (calaspargase pegol)
- aspirin / pravastatin
- Atamet (carbidopa / levodopa)
- Atorvaliq (atorvastatin)
- atorvastatin
- atorvastatin / ezetimibe
- Atripla (efavirenz / emtricitabine / tenofovir)
- Aubagio (teriflunomide)
- Augtyro (repotrectinib)
- auranofin
- Aurolate (gold sodium thiomalate)
- aurothioglucose
- Avandaryl (glimepiride / rosiglitazone)
- Avonex (interferon beta-1a)
- Avonex Pen (interferon beta-1a)
- Avonex Prefilled Syringe (interferon beta-1a)
- Avsola (infliximab)
More about ethionamide
- ethionamide consumer information
- Check interactions
- Compare alternatives
- Reviews (1)
- Side effects
- Dosage information
- During pregnancy
- Drug class: nicotinic acid derivatives
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.